Regeneron Pharmaceuticals | REGN - Trade Creditors


Regeneron Pharmaceuticals reported $1.14B in Trade Creditors for its fiscal quarter ending in September of 2026.





Trade Creditors Change Date
AbbVie USD 33.3B 29.71B Jun/2026
Agenus USD 58.98M 12.1M Jun/2026
Agios Pharmaceuticals USD 16.34M 2.6M Jun/2026
Alnylam Pharmaceuticals USD 135.4M 27.38M Sep/2026
Amgen USD 2.86B 16.65B Jun/2026
Astellas Pharma JPY 192.29B 7.47B Jun/2026
AstraZeneca USD 22.89B 388M Jun/2026
Biogen USD 430.3M 26.4M Sep/2026
BioMarin Pharmaceutical USD 913.67M 120.52M Jun/2026
Bristol-Myers Squibb USD 4.63B 470M Sep/2026
Eli Lilly USD 5.79B 319M Sep/2026
Gilead Sciences USD 934M 260M Sep/2026
GlaxoSmithKline GBP 15.63B 1.29B Sep/2026
Incyte USD 235.37M 1.16B Sep/2026
Ionis Pharmaceuticals USD 47.7M 21.67M Jun/2026
J&J USD 9.32B 94M Sep/2026
Kyowa Hakko Kirin JPY 125.29B 17.7B Jun/2026
Merck USD 3.83B 36M Jun/2026
Moderna USD 167M 6M Jun/2026
Neurocrine Biosciences USD 691.3M 145.8M Mar/2026
Novartis USD 4.26B 64M Jun/2026
Novartis USD 4.32B 134M Mar/2026
Pfizer USD 4.58B 75M Jun/2026
Puma Biotechnology USD 6.39M 962K Sep/2025
Regeneron Pharmaceuticals USD 1.14B 19M Sep/2026
Roche Holding CHF 5.54B 237M Jun/2026
Sanofi EUR 22.71B 219M Mar/2026
Sarepta Therapeutics USD 50.98M 19.39M Jun/2026
Teva Pharmaceutical Industries USD 2.72B 125M Jun/2026
Ultragenyx Pharmaceutical USD 39M 3M Jun/2026
United Therapeutics USD 497.8M 500K Jun/2026
Vertex Pharmaceuticals USD 3.61B 135M Jun/2026